video found at http://pro.moneymappress.com/NVXSENSORS49/LNVXQ2CD/
or you can read the transcript below
One Device to
End All Disease
And It Costs Less Than $50
What's inside this 14-millimeter chip may soon:
- End cancer, heart attacks, strokes... every illness
- Grow the revenue of an $11.1 billion industry by 63,000%
- Deliver $7 trillion in wealth to Americans who tap into the one tiny company that controls ALL THE PATENTS
Hello, my name is John Wilkinson.
And I want to welcome you to this Money Morning exclusive event...
"One Device to End All Disease."
Every year, 1.5 million Americans have a heart attack. More than 570,000 die of cancer.
Respiratory disease, Alzheimer's, stroke and diabetes kill 410,000 more.
But that's about to change.
A technology has emerged that has the leading voices of the medical community making some astounding claims.
"New Device May Prevent Heart Attacks." – CBS NewsImagine living in a world where you are never in danger of being stricken by disease.
"New hope for cancer cure! Experts hailed a breakthrough…" – Express UK
"Breakthrough could save millions of lives." – NASA
"The end of the disease era." – American Journal of Medicine
Where you no longer fear illness...
And where you experience the freedom that comes with knowing you have complete control over your quality of life.
There is a device that could make all of that a reality.
And it costs less than $50...
Joining me now is a 34-year Silicon Valley veteran.
He has been directly involved with the development of an early generation of this device.
And he has consulted the military and Fortune 500 companies concerning its current – and – future applications.
Michael Robinson, thank you for being here.
Michael:
It's my pleasure, John.
John:
Now Michael, your career as a senior advisor and board member for Silicon Valley venture capital firms...
This has placed you at the center of a lot of major tech innovations.
In the '80s, you were working with Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, as they used robotics to revolutionize the U.S. auto industry.
In the '90s, you were one of five people involved in early meetings for what would become known as "cloud computing."
Today that's a $160-billion-a-year industry.
And after the millennium you focused a great deal of time on cyber-security technologies.
You were even with Dave DeWalt, the CEO of cyber-security giant McAfee Inc., right before Intel acquired that company for $7.8 billion.
But, in recent years you were a strategic consultant to a company building an early prototype of this device...
A device that has the potential to end disease.
Michael:
That's right, John.
John:
And I should point out - that company sold for $126 million in cash back in 2007, because of this technology.
Michael:
That's just a drop in the bucket compared to what's coming.
Think about it.
It doesn't matter what your politics are or your religion, class, or education level...
Everyone in the world is worried about disease.
Cancer can steal as much as 22 years from a survivor's life...
Stroke 9 years...
If you're 50 or older and you get heart disease – it can rob you of over 24 years...
So what that means is that the market for a technology that can end disease is literally everybody.
Which is why John – that device in your hand is already part of an $11.1 billion industry.
But recent advancements, and these have been verified through numerous clinical trials and have been approved by the FDA.
These have shown this device is going to save millions of lives...
And from an economic standpoint what's about to occur is pretty exciting on its own.
John:
Michael, before we investigate this device, I want to mention this quickly because this is really incredible...
Currently you are Money Morning's Director of Technology Investing.
And you believe so much in this device, as do all of us at Money Morning...
That you're spearheading a $1 million venture.
You're delivering $1 million dollars to people all across the country who are participating in this event, today...
And they can use this money to get in on the ground floor with this disease-ending technology.
Michael:
This technology is going to create a lot of millionaires, John.
John:
Well obviously, with a million dollars on the line, this is something you believe strongly in.
Michael:
It's not what I believe that matters – it's what I can prove.
Wall Street analysts predict, and this is in writing John, that this device is going to unleash a 63,000% spike in revenue growth to that $11.1 billion industry...
And $11.1 billion is nothing to shake a stick at...
That kind of growth to an already established industry is unprecedented.
And this technology is going to create $7 trillion in new wealth.
That's not in 20 years. That's not in 10 years. That's between now and 2017.
John:
So Money Morning is prepared to hand out – literally a million dollars.
Later I want to talk about this opportunity and why we're doing it.
But let's just get to the big question...
How can this device end disease?
Michael:
John, what you're looking at right now is the world's smallest medical implant. It's only 14mm long.And it is specifically designed to end heart disease.
Now when you open it up...
You'll find a technology that's about to end all disease...
It's called MEMS.
John:
MEMS?
Michael:
Yes – M-E-M-S.
It stands for Micro-ElectroMechanical-Systems.
John:
So when you say this MEMS device is a medical implant for your heart, is it a new type of Pacemaker?
I mean – I've seen the aftermath of a Pacemaker procedure. And it isn't a walk in the park.
So when I hear "medical implant" that's what I think of. And quite frankly, and I know I'm not alone here... it sounds a little intimidating.
Michael:
John, Pacemakers are intimidating.
Have you ever seen one on an x-ray?That is not a small piece of machinery they put in there.
And to get that computer inside you a doctor cuts a hole in your chest, slides two wires down a major artery and attaches them to your heart.
And those wires are attached to that computer.
Plus, Pacemakers are dangerous in the age of modern technology.
MRIs, cellphones, even the magnets in the headphones of iPods have been proven to cause interference with the pacemaker's computer.
This MEMS device has nothing in common with a pacemaker.
John:
So where is it implanted?
Michael:
Just beneath the skin, John.
Doctors place it below your collarbone.
Chances are you've had splinters that were bigger and deeper than this little guy.
John:
So a pacemaker monitors and regulates your heartbeat...
If necessary, it can correct an irregular heartbeat.
But it can't stop a heart attack.
Are you saying this MEMS implant can?
Michael:
Yes, and a whole lot more.
There are 51 known indicators for heart disease.
Most doctors test for two or three of them.
Usually just blood pressure, cholesterol, and maybe triglycerides.
The rest are generally ignored. It's just too expensive.
But now it's possible to monitor all 51 of them, all of the time.
Once you understand what MEMS are – this becomes very clear.
So let's imagine we did open up this implant...
Inside we'll find this MEMS device and its four key components...
The first is a MEMS microsensor.
The one in this particular implant is actually big by MEMS standards.
These microsensors can be as small as a single micron. That's literally the size of a speck of dust. It's invisible to the naked eye.
With sensors so small, you can put dozens, or hundreds of them in a MEMS device – all playing different roles.
For this implant, there are 7 biosensors inside.
They're monitoring all 51 of those heart disease indicators around the clock.
They can do this because of another MEMS component inside this implant.
John, do you know how long a pacemaker lasts?
John:
5, maybe 10 years in a best-case scenario.
Michael:
So we're looking at a big window. A lot of uncertainty.
John:
And a lot of stress.
Michael:
Right, and when that battery gets low on power, you need surgery to replace it.
So there's another hospital visit, and another chance for something to go wrong.
Why risk it?
You don't have to with this MEMS implant.
It requires 1/100th of the power...
And that's where the magic really happens here.
Because it hardly requires any juice to run, this MEMS implant can use a new technology called "energy harvesting."
That's where you generate electricity from the environment.
From movement, vibrations...
Or, with MEMS implants... Body heat.
John:
So you're saying our own bodies can power these devices?
Michael:
Yes, your natural body temperature can keep MEMS running day and night.
It's monitoring your blood, heartbeat, all 51 indicators.
And it's monitoring your body around the clock.
John:
That's amazing.
Michael:
Yeah, it is amazing.
You have this tiny implant...
It's right below your skin, watching out for you 24 hours a day, 7 days a week.
No waiting rooms...
No doctor trying to sneak in a round of 18 holes before he looks at your results.
This implant is your own private physician that never takes a break.
John:
Okay, so these sensors are monitoring my body, but what is it doing with this enormous amount of data it's collecting...
I imagine to "end heart disease" it needs to make sense of it all and then do something about it.
Michael:
That's what the last two components inside this MEMS device are for.
The first is a MEMS microcomputer unit.
An MMCU.
This is how the data is compressed and analyzed so we can actually do something with it.
There's no risk of human error in interpreting this data, because the MEMS microcomputer does it.
And there's no chance of cross contamination in a lab, because your body is the lab.
Now, here's what's going to really blow your mind.
This is phenomenal.
Each MEMS device has what's called an "augmented fusion engine" built into it.
This allows multiple MEMS to work together through a wireless sensor network.
They create a fusion of intelligence...
Here's what I mean by that.
Through this MEMS augmented fusion engine – this intelligence is wirelessly sent from the implant to a MEMS device that's already built into your smartphone for tracking...
John:
So my cellphone has MEMS inside it currently?
Michael:
Absolutely...
The average smartphone now has 11 MEMS in it.
That number is about to jump to 25.
Remember, MEMS technology is currently an $11.1 billion industry.
This isn't a future tech... it's a now tech.
So, yes these MEMS are already there in your smartphone waiting for this intelligence to be sent from this MEMS implant where it's tracked and stored again.
But if it was just sent to your phone, that wouldn't really make a bit of difference in the grand scheme of things.
Which is why this same intelligence is also sent to your doctor's office.
Because your doctor's computer system also has MEMS built into it.
Together these three systems are cross-analyzing this intelligence continuously.
John:
So you and your doctor know in real time when some kind of medical attention is needed.
Michael:
But it doesn't stop there.
The MEMS in this implant...
The MEMS in your doctor's computer system and your smartphone...
Together they are continuously and anonymously communicating with a global network of MEMS devices.
This network is analyzing data together...Developing early warning systems...
And identifying the safest and most effective solutions...
Now, you and your doctor have the ability to pinpoint what were once undetectable traces of heart disease years, even decades in advance.
John:
So we can take steps to stop a potential heart attack, or heart disease, or stroke long before it would have happened.
Michael:
Exactly.
And if you already have a heart condition, this implant can save your life.
John:
That's a Nobel Prize-worthy accomplishment on its own there.
1 out of every 4 deaths is heart disease related...
So I understand how MEMS can prevent heart disease. But how can they save you if you already have it?
Michael:
The secret are those MEMS microsensors – the biosensors.
They can pick up on deadly catalysts that lead to heart attacks or strokes... like the breakdown of heart-specific muscle tissue...
It detects these red flags and it sets off an early warning system.
It sends an alert to your smartphone... and it sends this same alert to your doctor.
We're talking about many hours, or in some cases DAYS before a heart attack.
John:
I just want to be clear. MEMS don't totally "cure" heart disease in the traditional sense.
Michael:
We shouldn't have to cure heart disease, John. That's the point here.
We're trying to end it entirely.
There's a big difference between the two ideas.
Here's how I look at it...
The impact MEMS can have on heart disease, to me, is very similar to how we ended polio.
Doctors desperately tried to cure polio. No one ever did...
But Jonas Salk creates a polio vaccine and we effectively wiped it off the face of the earth.That's the true goal – the only way to end any disease...
Stop it from happening in the first place.
John:
So in that sense you could look at MEMS as a digital vaccine.
Michael:
A digital vaccine that is going to end every disease the same way it's going to end heart disease.
John:
Michael, you brought a quick video clip – I want to put it up on the screen now.
It shows MEMS in action "ending cancer" – let's take a look at it and then you can explain what we're seeing.
What you just saw...
That video is from the Korean Institute of Science, but doctors at Penn State University and the Cleveland Clinic are performing similar tests...
The commercial version is essentially a tube that acts as a a disease breathalyzer.
There are more than 300 different gases in our breath and doctors know that if certain gases are there, it's a tell-tale sign of diseases.
With cancer, our bodies react by producing an antibody that's specific to the kind of cancer.
And those antibodies can be detected by your breath.
So the patient blows into this tube for 10 seconds.
The MEMS device inside is very similar to the one in that implant.
The microsensors capture the data... the MEMS microcomputer unit transforms that data into intelligence...
The MEMS augmented fusion engine transmits that intelligence to our smartphones – to the doctor's office – and to a worldwide network of similar devices.
Together they create an early warning system that can alert you years, or decades in advance of any cancer threats.
John:
So before a malignant mass ever has the chance to develop, you can eradicate the threat.
Michael:
You know, the major problem with almost every form of cancer is that we just can't catch it early enough...
Look at lung cancer – it's one of the most deadly forms.
Every year it kills 158,000 Americans.
And the reason it's so deadly, John, is that many cases involve people who aren't even smokers.
Currently, you need a CT scan to detect lung cancer in its earliest stages – but if you're a non-smoker your doctor isn't going to, out of the blue, suggest you get one if you aren't showing any symptoms...
And even if your doctor did...
Because you aren't a smoker, your insurance company will probably balk at paying for the test.
John:
So people are faced with a dangerous "catch-22."
By the time a non-smoker, or his doctor, suspect they have lung cancer, it's often too advanced to cure.
Michael:
It shouldn't be that way at all... and it doesn't have to be that way.
If you catch that cancer early, when it's just an abnormality...
According to Massachusetts radiologist, Dr. Rodrick Williams "you can just take it out."
And "taking it out" could be done without surgery or chemotherapy.
If that tube discovers cancer in its earliest phases...
Thanks to this device, it could also potentially be knocked out with simple immune boosters.
John:
So, soon we'll all be getting checked for cancer during every routine exam with this MEMS device...
Michael:
It's as easy as checking blood pressure or temperature.
You can even use this device at home. All it needs is your smartphone.
And it costs under $50.
John:
It's remarkable.
You've got a couple more of these MEMS devices you want to talk about.
We have a picture of one that looks like a normal inhaler.Michael:
You're right it does look like a regular inhaler.
But like that implant – like that tube – this is actually a powerful MEMS device.
And it could keep the 40 million Americans with asthma and COPD from suffering an attack.
It could put an end to respiratory disease.
All you have to do is attach this MEMS device to the top of your inhaler.
It runs 24/7 around the clock.
It captures pollen and pollution levels wherever you go.
It tracks where and when you use the inhaler.
It sends this data to your smartphone... your doctor's office.
Everything is cross-analyzed.
And what's created is a complete personal profile of any respiratory threats... and where they're located.
But what's also happening is the MEMS device in the smartphone is communicating this data anonymously to doctors and fellow patients who are connected throughout a global network.
The end result, and if you've got asthma or another respiratory illness – you know how valuable this can be...
A precise map of the world is created with respiratory disease hot zones.John:
So, let's say I'm in Europe on vacation with my family and I'm about to enter one of these hot zones, what happens?
Michael:
It's very simple...
Your smartphone notifies you with an early-warning emergency alert.
It's telling you do not pass go... do not enter that hot zone.
And if you can't avoid it, now you know to take a quick dose of your medicine.
These inhalers are already being used around the world. They're FDA approved.
Here, in America they're starting to really pick up in California and Florida.
John:
It's pretty easy to see the pattern here.
Heart and respiratory diseases, cancer... everything...
These MEMS can end each of these diseases before you even get sick.
Michael:
Yeah.
And as these devices are adopted more widely and by younger and younger generations, we'll see them virtually eradicate these threats in the years ahead.
We're just scratching the surface.
One of the hottest new MEMS trends is called "Wearable Tech."
It's just beginning to catch hold in America, but in places like the UK you already have 6 million people embracing it.
The name says it all - wearable tech means MEMS are built into our clothing.
Take this wristband here.According to the University of Maryland Medical Center, six out of every 10 adults have some form of a sleeping disorder.
This simple wristband, and the MEMS built into it, is beginning to replace dangerous sleeping medications.
Studies show it improves the health of people wearing it by 26%. And that's after just a couple of weeks.
For people suffering from dementia, there are wearable technology MEMS sensors built into clothing that can:
- Remind them to take their medication
- Record video to replay later to assist with memory
- Locate them if they get lost
- Detect if they fall
Or, it identifies irregular panic patterns, such as a raised heartbeat, or unstable breathing...
The MEMS sends out an alert to doctors or loved ones.
John:
Michael, people prioritize their health over almost everything... To the point where if it's important enough, the price tag becomes just something you have to deal with.
Look at the money spent on heart disease.
$273 billion last year alone.
That figure was expected to rise $34 billion each and every year...
For the next 17 years.
But it looks like MEMS could eradicate this healthcare inflation.
Michael:
Yes, unfortunately, disease is big business in America.
From a healthcare cost standpoint it's destructive.
But from an investment standpoint it's a different story altogether.
Look at Pfizer – one of the biggest beneficiaries of healthcare inflation.
They developed Lipitor® – the best-selling drug of all time.
Lipitor® only treats high cholesterol – that's it.
It does nothing for the other 50 risk factors for heart disease.
And still, this medical "one trick pony" helped send Pfizer's stock up 1,484% after they released it.For the first time ever, MEMS can detect and help doctors stop all 51 factors.
And for under $50.
Look at Seattle Genetics...
Their stock ran up 1,350% after they released a treatment for Hodgkin's lymphoma.It's a terrible form of cancer that affects about 9,000 people a year.
If a treatment for 9,000 people creates a 1,350% windfall...
The value of a single device that costs less than a nice dinner out – and could end all1.6 million new cases of cancer a year – it's almost unfathomable.
It's the same with respiratory disease.
GlaxoSmithKline developed the COPD medicine Advair® – the third highest-selling drug of all time.This was the major catalyst that pushed GlaxoSmithKline's share prices up 465%.
You can even look at something as simple as sleep disorders...
60 million prescriptions for sleeping pills are filled every year in this country.
One of the most popular sleeping pills of the past decade is Ambien®. At its peak, Ambien®, was hitting $55.4 million in sales per week.
The company that controls Ambien®, Sanofi-Aventis, saw its stock surge more than 1,200% because of its popularity.MEMS can replace every one of those 60 million bottles of dangerous pills.
John:
It looks like with MEMS we may get the best of both worlds.
Lower healthcare costs... and a historic investment opportunity.
So how do people take advantage of it?
Michael:
John, the money is in the patents.
One company has developed, patented, and now controls some of the most powerful MEMS applications for clinical diagnostics, medical imaging and mobile health applications.
Everything we've been discussing.
And it's a fraction, only 1/30th the size of the big pharma giants.
Their MEMS have already been FDA approved so that's a major barrier to the market already out of the way.
What they're sitting on is one of the most lucrative "patent pipelines" I've ever come across.
John:
Can you explain what you mean by a "patent pipeline?"
Michael:
John, the implant, that inhaler, all of these miraculous products that are going to end disease...
They're being produced by different companies.
But the patents for the critical MEMS devices – they all lead to the same place.
One, tiny company.
Every one of those products that is produced has to pay the company with the patents.
And that's the patent pipeline.
These patent pipelines have created some of the biggest investment windfalls in recent history.
And it goes well beyond the medical industry.
Take ASML Holdings – they built an impressive 221-strong patent pipeline.That established them as one of the most powerful semiconductor firms in the world and created a 2,531% windfall for investors.
Thermo Fisher Scientific – they became the big player in devices like diagnostics tools, DNA sequencing, chemical analysis...
Their dominance was due to their 123 patents.
And this patent pipeline delivered a 1,196% gain for shareholders.
Look at NetApp, Inc... They controlled 234 patents for memory and storage technologies.
It made them the second most powerful company in their industry.
And it delivered a 2,075% payday for investors.
John:
So your point is – find a strong patent pipeline and you're going to find profits.
Michael:
We see it over and over again.
This small MEMS company – the companies on its client list – the companies in its patent pipeline – are a "who's who" of Silicon Valley and the Fortune 500.
Apple, Blackberry, Dell, Bosch, Ericsson, Hewlett Packard, Hitachi, HTC, Samsung, Seagate, Sony, Western Digital, Cisco – that's just to name a few.
John:
So how strong is this company's patent pipeline?
Michael:
They control an 800-strong, patent portfolio, John.
And it goes way beyond just medical uses.
Cisco – one of this MEMS company's clients. They've been talking about, the "Internet of Everything" or "Internet of Things."
John:
Yes, I think I've heard a little bit about that.
Michael:
Right.
Cisco's CEO, John Chambers, says that technology based on MEMS, "will be the biggest leverage point for IT."
And that's because, over the next few years, Cisco estimates that 50 billion different types of devices – not just medical devices, but also cellphones, computers, cars...
Practically everything will be incorporating multiple MEMS technologies to communicate with each other through the Internet.
Chambers also publicly declared his company was "ALL IN." He's making a financial commitment that goes well beyond billions of dollars towards the "Internet of Everything" and MEMS technologies.This is the cornerstone of his company's future plans.
And his MEMS are going to rely on the patents of a company not named CISCO.
What that means is a relatively unknown player in Silicon Valley is sitting on the patents for the MEMS that are going to be in practically everything.
Medical, automotive, industrial, defense...
You name it.Their 800-strong, patent pipeline covers them all.
John:
Michael, we mentioned at the beginning of our interview – and I want to quickly touch on it again before we continue...
You are spearheading a $1 million program here at Money Morning to help people get in at the early stages – to grab their piece of this company's MEMS patent pipeline.
Michael:
Yes, there is a really innovative way for folks to secure stakes in these patent rights for around $9 apiece.
John:
So with that million dollars you and Money Morning are allocating to this venture...
You're going to be able to deliver a lot of those patent stakes to a few lucky folks participating today...
Michael:
John, there's $7 trillion of MEMS wealth that's going to flood every corner of this country – these folks can be right there at the forefront of it all.
John:
Okay, so we're going to discuss that in a few moments, but let's quickly talk about some of the other exciting MEMS applications that are rolling out.
Michael:
One of my personal favorites is called CeNSE.
C-E-N-S-E.
John:
What does that stand for?
Michael:
"The Central Nervous System of The Earth."
John:
That's definitely an attention-grabbing title, what does it mean though?
Michael:
CeNSE is a bold collaboration between two clients of that company with the 800 MEMS patents...
HP and Shell.
The goal of CeNSE is to literally cover the entire planet with more than a trillion MEMS.
Each the size of a pushpin.And each is 100,000% stronger than previous technologies – and 100 million times more sensitive...
These tiny, little devices are so accurate they can detect movement one-billionth the width of a human hair.
Shell is kicking off CeNSE by covering 10 square kilometers around their drilling sites with about 1 million MEMS per location...
They are placed just under the ground.
Energy harvesting will allow them to run around the clock using very little power.
Each will be monitoring, detecting, and analyzing any seismic movement.
Through their MEMS augmented fusion engines they communicate with each other, and with MEMS inside HP's on-site supercomputers and networking systems.
So this collaboration between Shell and HP will allow them to identify the exact location of the sweet spots for each discovery. And which direction the oil is flowing.
John:
What kind of economic impact is CeNSE expected to deliver?
Michael:
Consider this...
These MEMS can increase production capabilities by 1,000% and cut costs in half.
So let's talk dollars and cents.
Right now, Shell gets $453 billion a year in revenue from their energy production.
So multiply that by 10...
That means Shell and HP are predicting that, because of MEMS, they'll soon find and extract $4.53 trillion... each year. And at half the cost.
John:
Since Shell and HP have publicly announced they're in the market for 1 trillion MEMS devices... And we know exactly where those devices are going to come from.
This is an investor's dream.
Michael:
It's really difficult to find comparisons.
We could talk about Halliburton...
Before they captured their first "fracking" patent, they were a $57.2 million company. Now they're $29 billion.
That means their patents helped them multiply their revenue 500 times over.
But Shell and HP aren't the only ones who will be writing this MEMS company essentially one blank check after another.
That's because this company's patent pipeline extends well beyond just the medical and energy business.
There's also at the center of a "smart technology" revolution that's unfolding.
John:
Everything does seem to be carrying the label "smart this... smart that."
Our TVs are smart, our phones are smart...
Michael:
All that means is everyday technologies have been given Einstein-like IQ boosts using MEMS.
Smart cities are an example of this.
Right now, Google, Microsoft and Intel are on the verge of a bidding war over a smart city infrastructure boom that's evolving.
Take Santander, a small city in Spain.
They already have more than 12,000 MEMS devices planted around the city. They're in the asphalt, on the street lights, on top of buses... all over.
They continuously measure everything from air pollution to open parking spaces.
MEMS are tracking and managing the city's power grid and trash disposal system.
So far the city has saved 25% on its electricity costs and 20% on its garbage expenses.
The results of this test were so successful it was rolled out to another small, European city.
Genoa in Italy.
Then it went big...
Paris has installed 1 million MEMS, smart city sensors.
Japan is installing these MEMS in two cities, Fujisawa and Mitaka.
We're even seeing this begin in America. A similar program has already been implemented into Holyoke, Massachusetts.
And the patents for those MEMS all can be traced back to one company.
John:
So it sounds like it won't be too long before this company's MEMS are helping to run pretty much every city around the world.
Michael:
For me, it's easy to see why, John.
It's no secret that America has an infrastructure problem. Our roads and bridges in many parts of the country are simply falling apart.
MEMS are going to solve this problem.
I've got a picture of the ones that are going to do it.
John:
Let's put that up on the screen now.
Michael:These MEMS bridge sensors are roughly the size of a cell phone... most of that is the protective casing.
They're placed on areas of a bridge that are structurally sensitive. The purpose is to constantly record movements, tilt, orientation.
They wirelessly talk to each other – and the MEMS in the computer systems, to detect patterns that could suggest damage.
And with energy harvesting they power themselves with the bridges' natural vibrations.
I met with General Robert Flowers concerning his use of MEMS with the Army Corps of Engineers.
He told me he wanted to use them to look inside beams where bridges are damaged, to precisely examine and make quick assessments of what needed to be done."He said that without MEMS this can take months to do.
But now he can do it in "real time."
It's estimated that MEMS will save up to $200,000 a year... per bridge.
John, we have more than 600,000 bridges in this country.
John:
The math speaks for itself.
Michael:
It does...
It's saying there is a lot of money to be made from MEMS being placed into smart cities and smart bridges.
$113 billion to be exact... and that's just between now and 2020.
After 2020, that's expected to grow exponentially into the trillions of dollars...
There's also a lot of money to be made from MEMS smart homes.
Walk into a new high-end home today and chances are you'll be greeted by a fully integrated MEMS network.
And it's all run from your phone or tablet.
You can remotely control your lights and heat... your security system... your locks.
If you want, you can even integrate medical MEMS into your home to wirelessly monitor your health.
This is already big business, but it's getting bigger. MEMS smart home ecosystems will soon ring up a hefty $60 billion in revenue.
Our cars are now smart.
There are at least 50 MEMS in most cars... in some higher-end models it's even more than that.
Automotive MEMS is about to hit $27.7 billion a year.
John:
Let's talk about MEMS and the military.
You mentioned your discussions with General Flowers concerning smart bridges.
But you've also worked with the CEOs of Boeing, ITT, Kratos, and SRA International...
Those are some of the most connected defense contractors in the world.
Is the military going "all in" with MEMS?
Michael:
John, the military has been using MEMS for years. In fact, they were early investors in MEMS R&D.
Major General Michael Mazzucchi and I had a meeting to discuss how MEMS are being used to conquer what he calls "the digital battlefield."
This is a really big deal.
Subs, fighter jets, tanks, artillery, troops, cruise missiles, and more are all sharing intelligence with each other simultaneously.
You have all these MEMS telling your commanders and allies exactly where you are... while at the same time the sensors and detectors in them are picking up on enemy movements, where their equipment is, and other dangers in the field.
That's life-saving intelligence for the troops on the ground, and it's an unbeatable tactical advantage for the commanders.
I personally know of four highly-sensitive MEMS programs.
The Air Force is using MEMS for what the Department of Defense calls, "5th generation fighter sensors."
The MQ-9/Block 5 aircraft program uses MEMS for the transfer, encryption, and communication of classified intelligence.
The program "Dominate in Unmanned Systems" integrated MEMS into unmanned underwater, aerial, and ground vehicles to carry out explosive detonation and surveillance assignments.
The Global Precision Attack program, involved 30,000 airmen working 41,000 hours of missions last year alone.
The total budget for these programs is classified.
But we do know that the Department of Defense is looking at MEMS as one of their main resources for streamlining operations by $487 billion between now and 2021.
And when it saves the military a lot of money, it creates windfall profits for the company that controls the patents.
John:
It's nearly impossible to overstate how much MEMS are changing the world.
50 billion types of devices.
Devices that are about to end disease, revolutionize how we identify and extract energy...
MEMS are leading technological revolutions with the "Internet of Everything" and the unprecedented growth of smart devices.
And one company controls the 800-strong, patent pipeline that's about to grow the MEMS industry 63,000% and create $7 trillion in new wealth between now and 2017.
Michael:
That's right, John...
One company.
And it's going to stay that way for as long as I can see.
John:
Let's talk about that.
How can they maintain their dominance?
Michael:
First off, they produce the lion's share of ALL MEMS devices.
Right now, they can put out four million a day. That's more than anyone else in the world.
And their production capabilities are growing exponentially each year.
But here's another big reason.
Think about what all of these devices have in common – they need to run through wireless networks and their operating systems to communicate with each other.
Well, this one company has secured a near-insurmountable advantage here.
It controls 75% of the Apple iOS market. 31% of the Android market. And 54% of the Windows OS market.
They have four times the market share of their closest competitor. They're running laps around everybody else.
So when a company is developing a MEMS health technology, and they want to ensure it's scalable across all operating systems both mobile and computer... there's only one clear choice.
John:
Now Michael, you haven't spent your career on Wall Street, or at an investment bank.
For the past three decades, you've been in the heart of Silicon Valley working alongside some of the biggest tech innovators. We talked about a few of them today.
You've been where the real money is – on the board of a venture capital firm.
You've been a senior advisor to venture capitalists...
You were even in on MEMS technology at its very earliest stages with a company that developed a prototype of what we've been talking about today...
So Michael, how can everyday folks get in on this once-in-a-lifetime opportunity?
Michael:
The truth is, until recently, the big profits from MEMS have been limited to venture capitalists – folks like me...
As well as scientists and entrepreneurs.
But that's changed.
I want to be absolutely clear: This opportunity isn't just for the big boys... the billionaires.
I've created a way to get in, near the ground floor, and get stakes in this company's patent pipeline.
That means every time a MEMS device is produced, or sold, that's tied to these patents, you could end up getting a piece of the action.
I've prepared a detailed briefing on this.
It's called "The One Device to End All Disease."
Like the name suggests, it examines every patent connected to this device that's ushering in the "End of Disease."
It goes into detail on why just three of this company's medical patents alone could soon be worth $255 billion a year.
Then it documents Shell's and HP's progress with their "Central Nervous System for the Earth" program...
That alone is set to uncover over $4.5 trillion a year in new energy at half the cost.
I explain the massive, $113 billion rewards to be reaped from MEMS in "Smart Cities" and "Smart Bridges."
I go even further into MEMS military capabilities.
But most important, I share how everyday Americans can now grab an aggressive piece of the patent rights of this single MEMS company for around $9.
These folks will be front and center as revenue from MEMS surges 63,000% and $7 trillion in new wealth is unleashed.
John:
Okay, this briefing, "The One Device to End All Disease."
It's going to be sent to members of your latest venture, Nova-X.
Now I want to take a few moments to talk about this, because you've done some amazing things in a very short window of time.
Michael:
John, Nova-X has a clear directive...
To get folks in on the ground floor with the most disruptive technologies hitting the market.
This report – "The One Device to End All Disease" – it's just the start.
Every month I send members my Nova-X Report.
This is where I introduce them to my contacts – CEOs, entrepreneurs, venture capitalists – sometimes military leaders and defense contractors...
I cover things like supercomputers, "big data," biological and longevity drugs, defense tech...
Anything with a flood of venture capital money beating down the doors.
And I show Nova-X members off-the-radar ways to profit from these technologies.
John:
Let's talk about some of these opportunities you've uncovered for members.
I want to just touch on each quickly, a lightning round of sorts.
Let's start with rare earth metals.
By now, I'm sure most people know what they are. They're in all of our electronics.
But early on you identified four rare earth companies that gave members the chance to cash in on 990% total returns.
Michael:
This is the same strategy I've used for decades.
Find a technology trend that has momentum...
Then, look for companies with the patents or exclusive rights to capitalize on that momentum...
In this case, it was Rare Elements Resources Ltd... Avalon Rare Metals Inc... Quest Rare Minerals... and Great Western Minerals Group.
And like you said, this one played out pretty well for members who saw those 990% total returns.
John:
Let's talk "robotic surgery."
You were ahead of the curve here too.
Michael:
In the heart of Silicon Valley – my neck of the woods – the money was talking here.
Everybody knew that robotic surgery was going to become a very popular treatment for cancer.
That made Accuray a no-brainer.
They invented, and patented, the first robotic radiosurgery system. It's called the CyberKnife®.
It's a completely non-invasive alternative – so that makes it much safer.
It delivers what's called stereotactic radiosurgery and body radiation therapy to patients.
John:
And folks who followed you had the opportunity to capture 169% gains after just three months from Accuray.
Let's talk 3D printing... more specifically 3D bioprinting and your play on Organovo.
Michael:
I'd love to. 3D bioprinting is a really exciting new development in medicine.
This is where doctors use a person's own DNA to bioengineer donor tissue.
Here's why that matters.
Every day, 18 people die waiting for an organ transplant.
And of the folks lucky enough to get one, up to 70% experience some form of organ rejections – meaning their body's immune system attacks the implanted tissue.
But when it's your own tissue being used, both of these problems are eliminated.
Organovo's 3D bioprinting patents were a mile ahead of anyone else in their field.
John:
Yes, and judging from what it delivered members... so were the gains...
200% in just 32 days.
Santarus is a similar story. Folks who followed you here had the chance to bank 196% gains after just 4½ months.
Michael:
Right.
Santarus is a pharmaceutical company that patented treatments for ulcers and type 2 diabetes.
Silicon Valley was buzzing about them long before most people ever heard their name, so they were on my watch list for a long time.
John:
Those are just a few examples, but I think folks get the idea of what you can deliver.
So let's step back and look at the big picture.
Over just the past 15 months, you've given members the opportunity to collect 28 double- or triple-digit winners.
And over the long run, the secret behind what you've created has caught a lot of attention.
In fact, a study commissioned by Harvard investigated this strategy...
They found that over the last 15 years, it's outperformed the stock market by 1,054%.
Going even further, your work has actually been nominated for a Pulitzer Prize, which is no easy accomplishment.
Michael:
John, what I've done is just tweaked the venture capital model a little bit so everyday Americans can get involved.
Where we're different is – generally speaking – venture capital investing involves dropping tens – even hundreds of millions of dollars into companies before they go public.
Now, billionaires can do that – God bless them.
But those opportunities sink 9 out of ten times.
And those billionaires don't care.
I set my sights a little higher, because everyday Americans can't afford to take risks like that.
With the Nova-X Report, I target investments that are already public, but because of a recent development, or innovation...
They are about to experience an IPO-like surge in their share price.
And we've been doing pretty well. Currently I have an 88% win rate.
John:
So instead of only hitting it big 1 out of 10 times like those billionaire venture capitalists, you're just about hitting 9 out of 10.
Michael:
John, the reason we've had such great success is I don't leave anything to chance.
When it's time to exit any opportunity, I send an instant email alert, explaining why it's time to maximize your gains.
I also give weekly intelligence rundowns that explore the economy, the markets, the groundbreaking technologies that are being developed...
And we review our current investment opportunities.
Members get access to my audio and video updates – here I go even deeper into my venture capital strategy and the targets we're following.
This gives me a chance to virtually bring you along on some of the private conversations I have with by contacts and big tech "insiders."
Plus, folks have 24/7 access to the Nova-X Report website where every communication is archived, as well as a performance review of all of our opportunities.
And to answer any questions about the service, I have a members' concierge service set up.
Folks can call and email my staff who are ready to help them with whatever they need.
John:
Now, I know when you consult with private clients, your fees can run into the tens of thousands of dollars per session.
So how much does a membership to Nova-X cost?
Michael:
John, a Nova-X membership is priced for serious investors. A full year normally costs $299.
But something as profound as this MEMS revolution just doesn't appear all that often.
So I want to make sure folks get the one thing they all need to hit the ground running...
Seed money.
John:
We've quickly mentioned this a couple of times.
You're leading a $1 million initiative that can help folks get started with this MEMS opportunity.
$1 million delivered to the hands of folks – right here – right now.
That's the seed money you're referring to.
Michael:
Exactly, John...
Today, I'm opening up 4,000 Nova-X membership slots.
And this million dollars is going to those 4,000 people...
I believe each of those new members could become millionaires off this single MEMS opportunity – and this seed money can give them a big head start.
It can secure stakes in those MEMS patent rights.
John:
So just doing that math quickly – you're cutting a $250 check for each new member.
Michael:
John, that was the original plan.
But we've had some pretty interesting developments that changed the situation on the ground.
You see, big money has just started flooding into this company...
BlackBerry founder, Mike Lazaridis, just invested $97 million of his own money into profiting off of MEMS tech.
Peter Diamandis of X-Prize fame – he just invested $10 million.
And now, major Hedge funds are quietly trying to stake their claims in this same company.
Proxima Capital Management just took a position worth $17.9 million.
George Soros' Soros Fund Management also made a $15.9 million investment in the company
So if people want to get in on this MEMS company, there's no time to waste.
And there's no time to cut – and mail – those $250 checks.
So instead – and I can't think of a faster way to put this money into people's hands – I'm going to instantly deduct that money from Nova-X's membership fee.
John:
So that means that instead of paying $299...
4,000 people today get a full-year membership to the Nova-X report for only $49...
Michael:
That's right, John. So the same day they get on board, they can put that $250 towards these MEMS patent rights.
They can look at this as playing with the house's money. It eliminates an enormous amount of risk.
John:
Now even with this "house money," folks need assurances this opportunity is right for them.
Michael:
I couldn't agree more.
And frankly, I don't want anyone to risk a single penny by investing in this service.
Folks who sign up can test-drive Nova-X , risk free for 90 days.
They can get my briefing on this MEMS opportunity and every Nova-X Report that follows for the next 3 months.
They should carefully examine my portfolio and decide whether to act on the recommendations.
Heck, folks can paper trade my recommendations for 90 days if they want to make sure it's right for them.
If after those 90 days, they're not 100% convinced this is right for them, just let me know.
I'll get every penny of their membership dues right back to them.
Now, like I mentioned earlier, in Silicon Valley, if you really believe in something, you put your money where your mouth is.
So here's what I'm going to do...
Anybody who joins today...
If that $250 doesn't turn into at least $20,000 in profits this year... I'm talking over the next 12 months...
I'll work for free.
I'll extend their Nova-X Report membership out another year "on the house."
John:
$250 into $20,000?
That's a bold promise.
Michael:
It's not really.
I'm banking on much more than that.
Apple – Google – HP – Shell – Cisco – every major innovator – they're making MEMS the focal point of their future.
And they all have to go through this company and its patents.
Bosch is an enormous, $70-billion-a-year German Engineering firm – they are in automotive technology, appliances, industrial applications...everything.
Both, Bosch's Deputy Chairman and CEO have come forward and declared that MEMS will drive what they're calling the fourth industrial revolution – industry 4.0...
So the steam engine, assembly line, Internet... Then MEMS.
That's how big this is.
And Bosch gets its MEMS technology from this company.
Revenue in the MEMS industry is going to grow 63,000% over the next 3 years.
So making $20,000 off of $250 in year 1 – that's a safe bet in my eyes.
John, we're talking about a technological revolution here. It's going to change the world... I just want to show folks how to get the most out of it.
John:
Michael Robinson, I can't thank you enough for being here today. For me it was truly an eye-opening experience.
Michael:
Thank you, John.
John:
And I'd like to thank you for joining us as we examined the "One Device to End Disease," but as you can see, MEMS are going to do so much more than that.
MEMS will create the "Central Nervous System of the Earth" and uncover $4.5 trillion dollars' worth of energy.
And MEMS are what's leading a smart revolution in our homes, cars, phones, and military.
50 billion separate devices will soon be communicating with one another.
And every device will require the MEMS technology that a single company controls the patent rights to.
To claim your stake in this company's 800 MEMS patents... to claim your piece of the $7 trillion of new wealth that's about to be created...
Simply click the button below now to secure your membership in Michael Robinson'sNova-X Report.
Or if you'd prefer to sign up by phone...
Simply call 1.800.513.6445 or 1.443.353.4487 (for international callers) from 9 am to 5 pm (Eastern Time) – and be sure to mention Priority Code LNVXQ2CD.
I'm John Wilkinson.
Good day.
December 2013
Copyright - 2014 Money Map Press, LLC. The Money Map Press is a publishing company that does not act as a personal investment advisor for any specific individual. Nor do we advocate the purchase or sale of any security or investment for any specific individual. The proprietary recommendations and analysis we present to readers is for the exclusive use of subscribers. Readers should be aware that although our track record is highly rated, and has been legally reviewed for presentation in this invitation, investment markets have inherent risks and there can be no guarantee of future profits. Likewise, our past performance does not assure the same future results. Warning: The past performance of any trade whether actual or hypothetical is not necessarily an indication of future results. Stocks, futures, currencies, commodities, CFDs, options and all types of investment trading can have large potential rewards, but also carry large potential risks. We make absolutely no representation that gains or losses demonstrated in services published by Money Map Press LLC are likely or achievable. Hypothetical trading examples also cannot possibly take into account the impact of liquidity or buyer and seller demand, and do not allow for slippage and associated trading costs and concerns. One must be aware of the risks and be willing to accept them in order to invest in the markets. One should never trade with money that one cannot afford to lose, and one must accept that there will be losses, and one must be able to sustain these losses, both from a financial as well as an emotional perspective. Recommendations are for the exclusive use of subscribers and can change at any time. This work is based on SEC filings, current events, interviews, corporate press releases, and what we've learned as financial journalists. It may contain errors and you shouldn't make any investment decision based solely on what you read here. It's your money and your responsibility.
